Skip to main content
Top

memo - Magazine of European Medical Oncology

Issue 4/2011

Content (14 Articles)

Short review

Cancer in the elderly and gender aspects – situation in Tyrol

S. Geiger-Gritsch, H. Mühlböck, L. Harrasser, W. Oberaigner

Short review

Gender and oncology: Pathological observations

W. Sterlacci, R. Stockinger, M. Fiegl

Review

Molecular oncology in lung cancer – between biomarkers and clinical application. Relevance of the Ras–Raf–MEK–ERK pathway

W. Berger, A. Pircher, M. Sibilia, L. Bubendorf, M. Filipits, M. Fiegl, M. Früh, C. Manegold, H. Popper, W. Hilbe

Consensus report

A histology-based algorithm in the molecular diagnosis of mutations of the epidermal growth factor receptor (EGFR)–in non-small-cell lung cancer (NSCLC)*

H. Popper, F. Wrba, U. Gruber-Mösenbacher, W. Hulla, R. Pirker, W. Hilbe, M. Studnicka, A. Mohn-Staudner, F. Ploner

Short review

Treatment of invasive aspergillosis in cancer patients

J. Auberger, G. Russ, R. Greil, A. Egle

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine